Oric Pharmaceuticals, Inc.·4

Jan 3, 5:41 PM ET

Chacko Jacob 4

4 · Oric Pharmaceuticals, Inc. · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Chacko Jacob
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-02+600,000600,000 total
    Exercise: $8.26Exp: 2035-01-01Common Stock (600,000 underlying)
  • Award

    Restricted Stock Unit

    2025-01-02+100,000100,000 total
    Common Stock (100,000 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock.
  • [F3]1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.

Documents

1 file
  • 4
    form4-01032025_100156.xmlPrimary